Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|February 21, 2014
Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitorsSameer H Issaq, Beverly A Teicher, Anne MonksJournal of Experimental & Clinical Cancer Research : CR|July 13, 2010
Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1Nicole D Fer, Robert H Shoemaker, Anne MonksClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Transcriptional profiling identifies altered intracellular labile iron homeostasis as a contributing factor to the toxicity of adaphostin: decreased vascular endothelial growth factor secretion is independent of hypoxia-inducible factor-1 regulationCurtis Hose, Gurmeet Kaur, Edward A Sausville, et al.Molecular Cancer Therapeutics|January 7, 2004
Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: a potential surrogate marker for patient sensitivityCurtis D Hose, Melinda Hollingshead, Edward A Sausville, et al.Journal of Experimental Therapeutics & Oncology|November 6, 2002
Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicityXin Lu, Shimei Gong, Anne Monks, et al.Molecular Pharmacology|February 28, 2003
Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoleAnne Monks, Erik Harris, Curtis Hose, et al.Molecular Pharmacology|December 8, 2005
Differential gene expression as a potential classifier of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole-sensitive and -insensitive cell linesAnders Wallqvist, John Connelly, Edward A Sausville, et al.Biochemical and Biophysical Research Communications|August 29, 2003
Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expressionJoachim B Schnier, Kayoko Nishi, Anne Monks, et al.Breast Cancer Research and Treatment|September 21, 2004
The experimental antitumor agents Phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft modelsIduna Fichtner, Anne Monks, Curtis Hose, et al.Cancer Informatics|December 26, 2017
Longitudinal Transcriptional Response of Glycosylation-Related Genes, Regulators, and Targets in Cancer Cell Lines Treated With 11 Antitumor AgentsJulia Krushkal, Yingdong Zhao, Curtis Hose, et al.Pageof 4